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The physiological role of the brain GLP-1 system in 
stress
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Abstract: Glucagon-like peptide-1 (GLP-1) within the brain is a potent regulator 
of food intake and most studies have investigated the anorexic effects of central 
GLP-1. A range of brain regions have now been found to be involved in GLP-1 medi-
ated anorexia, including some which are not traditionally associated with appetite 
regulation. However, a change in food intake can be indicative of not only reduced 
energy demand, but also changes in the organism’s motivation to eat following 
stressful stimuli. In fact, acute stress is well-known to reduce food intake. Recently, 
more research has focused on the role of GLP-1 in stress and the central GLP-1 
system has been found to be activated in response to stressful stimuli. The source 
of GLP-1 within the brain, the preproglucagon (PPG) neurons, are ideally situated 
in the brainstem to receive and relay signals of stress and our recent data on the 
projection pattern of the PPG neurons to the spinal cord suggest a potential strong 
link with the sympathetic nervous system. We review here the role of central GLP-1 
in the regulation of stress responses and discuss the potential involvement of the 
endogenous source of GLP-1 within the brain, the PPG neurons.
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1. GLP-1 is a regulator of homeostasis
Glucagon-like peptide-1 (GLP-1) is an incretin and neuropeptide best known for its role in glucose 
homeostasis and appetite regulation (Holst, 2007; Kreymann, Ghatei, Williams, & Bloom, 1987; 
Tang-Christensen et al., 1996; Turton et al., 1996; Wang et al., 1995). In the periphery, GLP-1 is re-
leased from L cells in the gut following ingestion of food (Vilsbøll et al., 2003). From the blood it 
reaches the pancreas where it acts on β-cells to enhance the secretion of insulin in response to 
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glucose while inhibiting the release of glucagon from α-cells (de Heer, Rasmussen, Coy, & Holst, 
2008; Holst, 2007; Ørskov, Holst, & Nielsen, 1988; Vilsbøll, Krarup, Madsbad, & Holst, 2003). In addi-
tion, peripheral GLP-1 has proliferative and protective effects on islet cells and inhibits gastric emp-
tying (Egan, Bulotta, Hui, & Perfetti, 2003; Farilla et al., 2002; Nauck et al., 1997). Central GLP-1, here 
defined as GLP-1 acting within the central nervous system (CNS), is well-established as a potent 
regulator of food intake (Barrera et al., 2011; Larsen, Tang-Christensen, & Jessop, 1997; Turton et al., 
1996; Williams, Baskin, & Schwartz, 2009). Within the brain, GLP-1 is produced in a subset of granule 
cells or short axon cells of the olfactory bulb, some pyramidal cells of the piriform cortex and a few 
neurons in the lumbar-sacral spinal cord (Larsen, Tang-Christensen, Holst, & Ørskov, 1997; 
Merchenthaler, Lane, & Shughrue, 1999; Thiebaud et al., 2016; Zheng, Cai, & Rinaman, 2015). 
However, the primary source of GLP-1 in the brain is in preproglucagon (PPG) neurons in the nucleus 
tractus solitarii (NTS) and the intermediate reticular nucleus in the lower brainstem (Merchenthaler 
et al., 1999). PPG neurons, also referred to as GLP-1 neurons, particularly in studies on rat, project 
throughout the brain to autonomic control centres and this projection pattern largely matches the 
expression of GLP-1 receptors in the brain (Larsen, Tang-Christensen, Holst, et al., 1997; Llewellyn-
Smith, Gnanamanickam, Reimann, Gribble, & Trapp, 2013; Llewellyn-Smith, Reimann, Gribble, & 
Trapp, 2011; Merchenthaler et al., 1999; Trapp & Cork, 2015; Vrang, Hansen, Larsen, & Tang-
Christensen, 2007). PPG neurons are activated in vitro and in vivo by a range of satiety hormones and 
peripheral signals relating to food intake and general homeostasis (Hisadome, Reimann, Gribble, & 
Trapp, 2010, 2011; Merchenthaler et al., 1999; Rinaman, 1999b; Trapp & Richards, 2013).
It is clear that central GLP-1 reduces food intake. What is less clear is the physiological purpose 
and cause of this anorexic response. Importantly, a reduction in food intake can be a response to not 
only decreased energy demand, but also to changes in the emotional state that reduces the motiva-
tion to eat, or to visceral malaise leading to reduced appetite. Early studies addressed the role of 
taste aversion and nausea in the regulation of food intake. NTS GLP-1 neurons were activated by 
intraperitoneal injection of LiCl, a compound which is well known to cause malaise and taste aver-
sion (Rinaman, 1999b). Furthermore, blockade of the GLP-1 receptor using the antagonist Exendin 
(9-39) reversed the LiCl-induced suppression of appetite in rat, suggesting a role for central GLP-1 in 
the response to malaise (Rinaman, 1999a). However, these results could not be reproduced in mouse 
(Lachey et al., 2005), suggesting that subtle, but important species differences may exist in the cen-
tral GLP-1 system. In another early attempt to anatomically dissect different GLP-1 actions in the 
brain, van Dijk and Thiele (1999) demonstrated that bilateral lesions in the PVN prevented the induc-
tion of satiety by GLP-1, but not the conditioned taste aversion observed with GLP-1. They also 
showed that lesions in the amygdala prevented GLP-1 induced taste aversion, but rats retained the 
GLP-1 induced reduction in food intake. These experiments clearly demonstrated the existence of 
two separate pathways for GLP-1 effects on satiety and malaise. As further evidence for a role of 
GLP-1 in the response to general malaise, there is now data supporting a link between inflammation 
and GLP-1 mediated reduction in food intake and the cytokine interleukin-6 (IL-6) has been shown 
to activate PPG neurons in the NTS (Anesten et al., 2016; Shirazi et al., 2013). More recent studies 
have revealed that GLP-1 receptor signalling in the mesolimbic system affects food intake by modu-
lating reward pathways (Dickson et al., 2012; Mietlicki-Baase et al., 2013, 2014) and that activation 
of GLP-1 receptors in the hippocampus, a region not traditionally associated with appetite regula-
tion, reduces food intake (During et al., 2003; Hsu, Hahn, Konanur, Lam, & Kanoski, 2015).
From all these emerging targets it is becoming evident that GLP-1 in the brain does not simply 
inhibit metabolically driven food intake, but that the reduced appetite may be part of a wider re-
sponse to emotional stress or visceral malaise (Ghosal, Myers, & Herman, 2013; Kinzig et al., 2003; 
Kreisler & Rinaman, 2016; Maniscalco, Kreisler, & Rinaman, 2012; Maniscalco, Zheng, Gordon, & 
Rinaman, 2015; Rinaman, 1999b). In this review we discuss the evidence for the involvement of 
central GLP-1 in the regulation of stress and consider the potential role of the central source of GLP-
1, the PPG neurons. Most evidence has been gathered in mouse and rat and since few anatomical 
and functional differences have been observed between species (including human and non-human 
primates), we assume here that most findings are relevant across species (Vrang & Grove, 2011; 
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Zheng et al., 2015), though any paradigms where conflicting evidence exists between species, will be 
highlighted. We begin by briefly describing the organism’s response to stress. In the next section, we 
review the evidence for a role for GLP-1 in the regulation of stress responses and finally we discuss 
the potential role of the central source of GLP-1, the PPG neurons, in the stress response.
2. Stress activates two parallel coping systems, the hypothalamic-pituitary axis and 
the sympathetic nervous system
Stress is defined as the collection of physiological responses to homeostatic (physical) and psychologi-
cal (perceived) challenges (Dayas, Buller, Crane, Xu, & Day, 2001; Sawchenko, Li, & Ericsson, 2000; 
Ulrich-Lai & Herman, 2009). Stress allows the organism to cope with aversive stimuli and appropriate 
stress responses are essential to the survival of the organism. On the other hand, inappropriate chronic 
stress responses can lead to long-term damaging disorders such as anxiety and depression. Neural 
control of stress responses is complex and involves forebrain, brainstem and spinal cord circuits that 
ultimately converge to activate two important effectors in the body’s response to stress: the sympa-
thetic part of the autonomic nervous system (SNS) and the hypothalamus-pituitary-adrenal (HPA) axis 
(Ulrich-Lai & Herman, 2009) producing the so-called “fight-or-flight” response (Figure 1). A perceived 
threat to homeostasis and the well-being of the organism leads to rapid activation of the SNS. Heart 
and blood pressure are increased via recruitment of catecholaminergic neurons in the rostral ventrolat-
eral medulla (RVLM), the raphe pallidus and sympathetic preganglionic neurons in the spinal cord as 
well as higher order autonomic control sites in the hypothalamus and amygdala (Dampney, 1994; 
Dayas et al., 2001; Dimicco & Zaretsky, 2007). Increased sympathetic activity leads to release of adren-
aline from the adrenal medulla and adrenaline in turn increases cardiac output and respiratory rate 
while redirecting blood flow to skeletal muscle and mobilising glucose from liver and skeletal muscle 
(Ulrich-Lai & Herman, 2009). The parallel recruitment of the HPA axis involves the activation of parvo-
cellular neurons in the paraventricular nucleus of the hypothalamus (PVN). These neurons release cor-
ticotrophin-releasing hormone (CRH) onto adrenocorticotropic hormone (ACTH) expressing neurons in 
the anterior pituitary. From the pituitary, ACTH is released into the bloodstream through which it reach-
es the cortex of the adrenal gland. In the adrenal cortex ACTH elicits release of corticosterone, which 
works to mobilise glucose by stimulating gluconeogenesis securing the body’s demand for glucose 
during homeostatic challenges (Ulrich-Lai & Herman, 2009). Corticosterone provides negative feedback 
at the level of the pituitary and the hypothalamus to limit HPA activity (Ulrich-Lai & Herman, 2009).
3. GLP-1 activates both the HPA axis and the sympathetic nervous system
The majority of evidence for a role of GLP-1 in stress has been gathered using supraphysiological 
doses of GLP-1 or GLP-1 analogues (typically Exendin-4) to activate GLP-1 receptors both peripher-
ally and centrally. These studies have shown that recruitment of central GLP-1 receptors potently 
activates the HPA axis in both humans and rodents with a resulting increase in both ACTH and corti-
costerone/cortisol concentrations in blood (Gil-Lozano et al., 2010; Kinzig et al., 2003). The adrenal 
cortex does not express GLP-1 receptors and isolated cells from the adrenal glands do not release 
corticosterone in response to GLP-1 ruling out the possibility that GLP-1 acts directly on the adrenal 
cortex (Dunphy, Taylor, & Fuller, 1998; Gil-Lozano et al., 2014). Importantly, central administration 
of Exendin-4 leads to an increase in corticosterone in rodents, suggesting an involvement of central 
GLP-1 receptors possibly expressed on CRH expressing neurons in the hypothalamus (Gil-Lozano et 
al., 2014; Larsen, Tang-Christensen, & Jessop, 1997; Sarkar, Fekete, Légrádi, & Lechan, 2003). In fact, 
central blockade of CRH receptors blocks Exendin-4-induced increases in ACTH and corticosterone, 
establishing a role for central GLP-1 receptors in HPA axis regulation (Gil-Lozano et al., 2014).
In a study investigating the involvement of central GLP-1 in both homeostatic and psychogenic 
stress, Kinzig et al. (2003) found that injections of GLP-1 into the PVN increased blood ACTH and cor-
ticosterone concentrations. Targeting the amygdala increased anxiety-like behaviour with animals 
spending significantly less time in the open arms of an elevated plus maze after infusion of GLP-1. 
Different types of stressors, i.e. homeostatic vs. psychogenic, are known to activate distinct neural 
pathways and the data described above suggests that GLP-1 regulates both homeostatic and psy-
chogenic stress responses through distinct neural pathways (Dayas et al., 2001; Kinzig et al., 2003).
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Intriguingly, activation of central GLP-1 receptors not only stimulates the HPA axis, but also ap-
pears to increase sympathetic activity, the other important pathway for the physiological response 
to stress (Smits et al., 2016; Yamamoto et al., 2002). This is measured as an increase in heart rate in 
both rodents and humans following GLP-1 receptor activation (Gil-Lozano et al., 2014; Griffioen et al., 
2011; Robinson, Holt, Rees, Randeva, & O’Hare, 2013; Smits et al., 2016; Yamamoto et al., 2002). 
Central GLP-1 receptor activation was found to stimulate both autonomic regulatory neurons, neu-
rons in the spinal cord and cells in the adrenal medulla signifying clear recruitment of the sympa-
thetic nervous system (Yamamoto et al., 2002). This suggests that central GLP-1 could activate both 
arms of the stress response, the HPA axis and the sympathetic nervous system.
4. NTS GLP-1 neurons are ideally situated to integrate signals of stress
Studies using supraphysiological activation of GLP-1 receptors provide little information about the 
physiological role of the endogenous GLP-1 system in stress regulation. Exogenous activation of 
central GLP-1 receptors clearly triggers release of ACTH and corticosterone, but the question re-
mains, whether there is an endogenous source of GLP-1 eliciting these responses under physiologi-
cal conditions? Further, which signals trigger release of GLP-1 from that source? GLP-1 released from 
L cells in the gut is rapidly degraded in the liver and bloodstream making it unlikely that GLP-1 
reaches receptors in the brain in large quantities (Deacon, 2004; Hansen, Deacon, Ørskov, & Holst, 
1999; Holst & Deacon, 2005; Kieffer, McIntosh, & Pederson, 1995; Vilsboll, Krarup, Deacon, Madsbad, 
& Holst, 2001). In contrast, the central source of GLP-1, the PPG neurons, are ideally situated in the 
NTS in the caudal brainstem to receive and process signals of stress from the rest of the body (Kreisler 
& Rinaman, 2016; Maniscalco et al., 2012; Merchenthaler et al., 1999; Rinaman, 1999b; Vrang, Phifer, 
Corkern, & Berthoud, 2003). The NTS is a well-established central site of integration of visceral affer-
ent signals concerning general homeostasis, which are relayed to higher brain centres (Grill & Hayes, 
2012). From the NTS, PPG neurons project to autonomic control sites throughout the brain including 
the PVN, the dorsomedial hypothalamus and the RVLM, which are all involved in the control of the 
HPA axis and/or sympathetic activity (Larsen, Tang-Christensen, Holst, et al., 1997; Llewellyn-Smith 
et al., 2011, 2013; Vrang et al., 2007). In the PVN, there is dense expression of GLP-1 receptors and 
GLP-1 immunoreactive axons make contact with parvocellular CRH producing neurons, supporting a 
role for PPG neurons in the regulation of CRH secretion from the hypothalamus (Cork et al., 2015; 
Larsen, Tang-Christensen, Holst, et al., 1997; Sarkar et al., 2003).
NTS neurons are generally thought to regulate sympathetic activity indirectly through ascending 
projections to either the RVLM or hypothalamic nuclei. Recent findings in our laboratory have dem-
onstrated that PPG neurons in the brainstem not only send ascending projections to autonomic 
control sites mainly in the hypothalamus, but also directly innervate sympathetic preganglionic neu-
rons in the spinal cord (Llewellyn-Smith et al., 2015). These data highlight the possibility that the 
central GLP-1 system may integrate incoming stress signals and relay them via both ascending pro-
jections to CRH neurons in the PVN to elicit HPA activity and descending projections to preganglionic 
sympathetic neurons in the intermediolateral column (IML) and central autonomic area (CAA) of the 
spinal cord to increase sympathetic outflow.
Figure 1. Stressors activate 
forebrain and brainstem 
regions to prepare for 
“fight-or-flight”.
Notes: Acute injury or a perceived 
threat leads to activation of 
psychogenic and/or homeostatic 
stress. Psychogenic stress 
recruits areas in the limbic 
areas of the forebrain, including 
the hippocampus and the 
amygdala, which influence 
the activity of hypothalamic 
nuclei. A homeostatic challenge 
activates brainstem nuclei, which 
either relay this information to 
hypothalamic regions or directly 
to sympathetic preganglionic 
neurons in the spinal cord. 
The hypothalamus receives 
modulatory input from forebrain 
and medullary nuclei and is the 
main driver of the HPA axis (in 
blue) and the sympathetic nervous 
system (SNS, in green). Release of 
corticotropin-releasing hormone 
(CRH) from parvocellular neurons 
in the paraventricu        lar nucleus 
of the hypothalamus on cells 
expressing adrenocorticotropic 
hormone (ACTH) leads to release 
of ACTH into the bloodstream 
via the blood, ACTH reaches the 
adrenal cortex where it stimulates 
the release of corticosterone 
(cortisol in humans). 
Corticosterone mobilises glucose 
by increasing gluconeogenesis 
and by counteracting the effects 
of insulin. Parallel activation of 
the SNS (green) leads to release 
of adrenalin from postganglionic 
sympathetic neurons onto target 
tissues, including blood vessels, 
the adrenal medulla, heart and 
the respiratory system. This 
leads to increased muscle blood 
flow and decreased blood flow 
to the organs in the abdominal 
cavity (splanchnic blood flow) 
ensuring sufficient oxygen and 
energy supply to the muscles. 
The secretion of adrenaline from 
the adrenal medulla into the 
blood further increases heart 
and respiratory rate and the 
mobilisation of glucose through 
glycogenolysis and lipolysis.
Page 5 of 9
Holt & Trapp, Cogent Biology (2016), 2: 1229086
http://dx.doi.org/10.1080/23312025.2016.1229086
In a thorough dissection of HPA-GLP-1 crosstalk, Lee et al. (2016) explored the neural pathways 
underlying GLP-1 receptor initiated increases in corticosterone in rat. Systemic (intraperitoneal; i.p.) 
exendin-4 activated catecholaminergic (CA), non-PPG neurons in the NTS and RVLM. Most of these 
neurons were found to project to the parvocellular and magnocellular PVN. Selective ablation of this 
CA-PVN connection using DBH-saporin prevented the i.p. exendin-4 induced increase in blood con-
centrations of corticosterone. This demonstrated that activation of the HPA axis by systemic ex-
endin-4 is dependent on CA input to the PVN. On first sight this seems surprising given that PPG 
neurons project heavily to the PVN and make contacts to CRH neurons as discussed above. However, 
keeping in mind that PPG neurons do not express GLP-1 receptors, these findings might just indicate 
that the peripheral and central GLP-1 systems are more separate than widely thought. It also em-
phasises that still more studies are needed that explore which exact peripheral signals activate PPG 
neurons and which do not.
5. The central GLP-1 system is activated in response to both homeostatic and 
psychogenic stress
An early study suggesting a link between central GLP-1 and stress was conducted by Rinaman 
(1999b). Interoceptive stress was induced through intraperitoneal injection of LiCl. LiCl is considered 
a nauseogenic agent and is known to reduce food intake while increasing the concentration of stress 
hormones ACTH and corticosterone in the blood (Kinzig, Hargrave, & Honors, 2008). LiCl was found 
to activate GLP-1 neurons in the NTS which were found to project to the HPA-regulating parvocellular 
region of the PVN (Rinaman, 1999b). Kinzig et al. later demonstrated that the LiCl-induced increase 
in stress hormones is dependent on central GLP-1 signalling (Kinzig et al., 2003). Third ventricular 
infusion of a GLP-1 receptor antagonist abolished the increase in both ACTH and corticosterone fol-
lowing systemic LiCl injections. The discovery of close appositions from GLP-1 immunoreactive axon 
terminals on CRH producing PVN neurons in rat further substantiate these findings (Tauchi, Zhang, 
D’Alessio, Stern, & Herman, 2008). Similarly, axons of mouse PPG neurons have close appositions on 
CRH producing PVN neurons (personal communication, Ida Llewellyn-Smith). These data suggest 
that homeostatic stress following a toxic challenge activates the central GLP-1 system to recruit 
systemic stress pathways.
Similarly, acute psychogenic stress induced by physical restraint reduces food intake and activates 
the HPA axis (Kinzig et al., 2008). Maniscalco et al. recently demonstrated that the number of cFOS 
positive GLP-1 neurons increases following 30mins restraint stress or 5mins exposure on an elevated 
platform, suggesting that GLP-1 neurons are activated by psychogenic stress (Maniscalco et al., 
2015). Furthermore, they found that 30 mins restraint stress reduced food intake at the onset of 
dark phase and that this hypophagic response was blocked by central infusion of GLP-1 receptor 
antagonist, suggesting that psychogenic stress recruits the central GLP-1 system to reduce food in-
take (Maniscalco et al., 2015).
Finally, in a study focusing on the role of GLP-1 in cocaine addiction, GLP-1 neurons were found to 
be activated by an injection of corticosterone into the fourth ventricle (Schmidt et al., 2016). Fourth 
ventricle corticosterone reduced cocaine self-administration and this reduction was blocked by GLP-
1 receptor antagonism in the ventral tegmental area (Schmidt et al., 2016). These data suggest that 
not only does central GLP-1 activate the HPA axis, but corticosterone in turn activates the central 
GLP-1 system.
6. Conclusions
It is clear that the central GLP-1 system plays a role in the regulation of food intake. However, in-
creasing numbers of studies report effects of GLP-1 in brain regions not classically associated with 
appetite control and it is becoming increasingly clear that central GLP-1 may be responsible for 
much wider homeostatic control. In particular, the anorexic effects of GLP-1 may in some cases be 
secondary to responses to homeostatic and psychogenic stress.
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We have discussed here evidence for a role of central GLP-1 in the regulation of the body’s stress 
response. It is clear that overactivation of brain GLP-1 receptors enhances secretion of stress hor-
mones and activity of the SNS. In contrast, the role of the central source of GLP-1, the PPG neurons, 
is less explored and the neural pathways underlying the GLP-1 mediated modulation of stress are 
largely unknown. The evidence discussed here suggests a model in which peripheral signals of ho-
meostatic and psychogenic stress activate PPG neurons (Figure 2). The PPG neurons are ideally situ-
ated in the NTS to integrate signals of stress and relay that signal on to parvocellular neurons in the 
PVN. Furthermore, in this model psychogenic or homeostatic stress would lead to release of GLP-1 
from PPG neurons. Downstream activation of GLP-1 receptors then increases sympathetic activity 
via direct and indirect pathways. Directly, PPG neurons modulate the activity of sympathetic pregan-
glionic neurons in the spinal cord. Indirectly, GLP-1 from PPG neurons activates presympathetic 
RVLM and PVN neurons which in turn project to spinal sympathetic preganglionic neurons.
The evidence discussed here suggests that central GLP-1 does not simply regulate food intake in 
response to changes in energy demand, but that the PPG neurons are activated by stress and that 
central GLP-1 modulates acute stress, homeostatic or psychogenic, by increasing corticosterone, 
mobilising glucose and increasing heart rate, allowing the organism to cope with potential threats.
Figure 2. PPG pathways to 
activate both HPA axis and 
sympathetic nervous system in 
the control of stress responses.
Notes: PPG neurons in the 
nucleus of the solitary tract 
(NTS) and the intermediate 
reticular nucleus (IRT) are 
activated by stressors. 
Activation of PPG neurons leads 
to release of GLP-1 (orange) 
onto parvocellular cells in the 
PVN, which in turn activate 
the HPA axis (blue arrows) by 
stimulating cells in the pituitary 
to release adrenocorticotropic 
hormone (ACTH). ACTH acts on 
the adrenal cortex to increase 
the secretion of corticosterone. 
In parallel, PPG neurons 
send descending axons 
directly to spinal sympathetic 
preganglionic neurons in the 
intermediolateral column 
(IML) and ascending axons to 
presympathetic neurons in VLM 
and PVN. Recruitment of PVN 
and VLM neurons also leads to 
activation of the sympathetic 
nervous system (green arrows) 
via descending fibres to the 
sympathetic preganglionic 
neurons in the IML in the spinal 
cord, which in turn increase 
heart rate and stimulate the 
release of adrenaline from the 
adrenal medulla.
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